These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15738861

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Continuing clozapine treatment despite neutropenia.
    Esposito D, Rouillon F, Limosin F.
    Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
    [Abstract] [Full Text] [Related]

  • 28. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G, Eskelinen S, Sailas E.
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract] [Full Text] [Related]

  • 29. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E.
    BMC Psychiatry; 2016 Dec 12; 16(1):441. PubMed ID: 27955666
    [Abstract] [Full Text] [Related]

  • 34. Prevention of clozapine-induced neutropenia by pretreatment with lithium.
    Silverstone PH.
    J Clin Psychopharmacol; 1998 Feb 12; 18(1):86-8. PubMed ID: 9472850
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E, Taylor D.
    CNS Drugs; 2007 Feb 12; 21(1):25-35. PubMed ID: 17190527
    [Abstract] [Full Text] [Related]

  • 38. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F, Tsang P, Barr AM.
    Am J Psychiatry; 2013 Oct 12; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract] [Full Text] [Related]

  • 39. Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia.
    Schuld A, Kraus T, Hinze-Selch D, Haack M, Pollmächer T.
    Acta Psychiatr Scand; 2000 Aug 12; 102(2):153-5. PubMed ID: 10937789
    [Abstract] [Full Text] [Related]

  • 40. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ, Cho MJ, Oh JT, Lee Y, Chae BJ, Ko J.
    Hum Psychopharmacol; 2006 Aug 12; 21(6):387-91. PubMed ID: 16933201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.